Drugs / PF-07832837
last change Nov 2024 re-read 3 minutes ago

PF-07832837

Developed for
atopic eczema
Investigated by
Pfizer

Trials 1

202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT06564389 Nov 2024 → Jun 2027 expected atopic eczema Pfizer Recruiting No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as PF-07832837 ClinicalTrials.gov intervention name — accepted as the source's own label NCT06564389 ↗